Showing results (81-90 of 235) with videos related to

Sort By:
Pageof 24
Journal of Neuropathology and Experimental Neurology|February 22, 2022
Prognostic Relevance of Transforming Growth Factor-β Receptor Expression and Signaling in Glioblastoma, Isocitrate Dehydrogenase-WildtypeClaudio Togni, Emanuel Rom, Isabel Burghardt, et al.
Journal of the Neurological Sciences|February 12, 2026
Persistent parvovirus B19 DNAemia in B-cell depletion: Implications for family planning in multiple sclerosis and related disordersLorenz Karnbrock, Marina Herwerth, Guido Vincent Bloemberg, et al.
Oncotarget|January 8, 2016
Control of glioma cell migration and invasiveness by GDF-15Paula Codó, Michael Weller, Kerstin Kaulich, et al.
Oncotarget|October 4, 2014
MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escapePaula Codo, Michael Weller, Gunter Meister, et al.
Neuro-Oncology|December 25, 2010
APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivoGünter Eisele, Patrick Roth, Kathy Hasenbach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2017
NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against GlioblastomaTobias Weiss, Hannah Schneider, Manuela Silginer, et al.
Molecular Cancer Therapeutics|April 6, 2017
Biological Role and Therapeutic Targeting of TGF-β3 in GlioblastomaKatharina Seystahl, Alexandros Papachristodoulou, Isabel Burghardt, et al.
Nature Reviews. Neurology|May 13, 2017
Vaccine-based immunotherapeutic approaches to gliomas and beyondMichael Weller, Patrick Roth, Matthias Preusser, et al.
European Journal of Neurology|May 12, 2022
Venous thromboembolic events in glioblastoma patients: An epidemiological studyAmanda Eisele, Katharina Seystahl, Elisabeth J Rushing, et al.
Pageof 24